Skip to main content
Clinical Trials/CTRI/2024/07/070099
CTRI/2024/07/070099
Not yet recruiting
Phase 2

Impact of Motivational Enhancement Therapy in Cessation of Tobacco Use in Patients of Schizophrenia: An Interventional Study in Rural Central India - Nil

Datta Meghe Institute of Higher Education and Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Datta Meghe Institute of Higher Education and Research
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Datta Meghe Institute of Higher Education and Research

Eligibility Criteria

Inclusion Criteria

  • a)Patients who are clinically diagnosed to have Schizophrenia using the International Classification of Diseases 11th revision (ICD\-11\) research criteria and who are using tobacco in any form.
  • b)Patients within the age group of 18 to 65 years.
  • c)Patient should be able to give written informed consent.

Exclusion Criteria

  • a)Subjects not willing to give written informed consent.
  • b)Patients who are acutely ill or not able to cooperate with the study
  • c)Patients who have a history of developmental delay or any other major organic brain pathology.
  • d)Patients who had past history of head injury.

Outcomes

Primary Outcomes

Not specified

Similar Trials